Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Providers
Hospitals
Practices
Retail
Health Tech
AI and Machine Learning
Digital Health
Telehealth
Payers
Regulatory
Finance
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Webinars
Fierce Events
Industry Events
Podcasts
Survey
Whitepapers
Events
Subscribe
Subscribe
Providers
Hospitals
Practices
Retail
Health Tech
AI and Machine Learning
Digital Health
Telehealth
Payers
Regulatory
Finance
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Webinars
Fierce Events
Industry Events
Podcasts
Survey
Whitepapers
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Hims & Hers
Health Tech
Health tech Q3 earnings recap—Hims & Hers, Doximity, Waystar
Buoyed by strong results in the most recent quarter, Hims & Hers, Doximity and Waystar all raised their 2024 revenue and profitability outlooks.
Heather Landi
Nov 15, 2024 11:00am
Amazon One Medical offers subscription-based medical treatments
Nov 14, 2024 9:00am
Hims & Hers to buy compounding pharmacy to make weight loss meds
Aug 6, 2024 7:00am
Hims & Hers adds GLP-1 injections to its weight loss program
May 20, 2024 9:00am
Hims & Hers bumps up 2024 revenue forecast to $1.2B
May 7, 2024 5:00pm
Health tech Q4 earnings recap—Hims & Hers reaches profitability
Mar 1, 2024 3:00pm
